Breast cancer represents a leading cause of death worldwide. Despite the advances in
systemic therapies, the prognosis for patients with breast cancer liver metastasis (BCLM) …

Selective internal radiation therapy (SIRT) with microspheres labelled with the β-emitter
yttrium-90 (Y-90) enables targeted delivery of radiation to hepatic tumors. SIRT is primarily …

This study aimed to investigate the distribution laws and research frontiers of international
literature, so as to present a holistic bibliometric evaluation of the studies on breast cancer …

Minimally invasive locoregional therapies have a growing role in the multidisciplinary
treatment of primary and metastatic breast cancer. Factors contributing to the expanding role …

Liver malignancy, including primary liver cancer and metastatic liver cancer, has become
one of the most common causes of cancer-related death worldwide due to the high …

Purpose Transarterial radioembolization (TARE) is a treatment for liver tumours based on
injection of radioactive microspheres in the hepatic arterial system. It is crucial to achieve a …

Purpose Quantification of post-interventional adverse events of outpatient SIRT leading to
hospitalization and quantification of radiation exposure. Materials and methods In this single …

Background Few studies of proton beam therapy (PBT) for patients with liver metastasis from
breast cancer (LMBC) are available to date. The aim of the present study was to evaluate the …

Introduction The aim of this study is to conduct a meta-analysis to assess the efficacy of
yttrium-90 selective internal radiation therapy (SIRT) in treating patients with breast cancer …

Purpose To determine pre-therapeutic predictive factors for overall survival (OS) after yttrium
(Y)-90 radioembolization (RE). Methods We retrospectively analyzed the pre-therapeutic …